NovaBay Pharmaceuticals (NBY) announces three new composition of matter patent issuances in...

|About: NovaBay Pharmaceuticals, Inc. (NBY)|By:, SA News Editor

NovaBay Pharmaceuticals (NBY) announces three new composition of matter patent issuances in Australia, New Zealand and Mexico and four Notices of Allowance in Canada, Japan, South Africa and Mexico on its proprietary Aganocide compounds which includes its lead compound, NVC-422.